首页|期刊导航|Pharmacoeconomics and Policy|Linked pharmacometrics-pharmacoeconomics model for cost-effectiveness analysis of tacrolimus in liver transplant patients from real-world data
Linked pharmacometrics-pharmacoeconomics model for cost-effectiveness analysis of tacrolimus in liver transplant patients from real-world data
Aole Zheng Wen Yao Maka Xiaoping Shi Xinyue Zhang Jiaqi Ni Yunrong Shen Zhen Feng Donghui Lao Xiao Zhu Xiaoqiang Xiang Qingfeng He
Pharmacoeconomics and Policy2026,Vol.2Issue(2):P.110-118,9.
Pharmacoeconomics and Policy2026,Vol.2Issue(2):P.110-118,9.DOI:10.1016/j.pharp.2026.06.008
Linked pharmacometrics-pharmacoeconomics model for cost-effectiveness analysis of tacrolimus in liver transplant patients from real-world data
摘要
关键词
Pharmacometrics-pharmacoeconomics/Physiologically-based/pharmacokinetics/Cost-effectiveness/analysis/Tacrolimus/Diltiazem/Liver/transplantation分类
医药卫生引用本文复制引用
Aole Zheng,Wen Yao Maka,Xiaoping Shi,Xinyue Zhang,Jiaqi Ni,Yunrong Shen,Zhen Feng,Donghui Lao,Xiao Zhu,Xiaoqiang Xiang,Qingfeng He..Linked pharmacometrics-pharmacoeconomics model for cost-effectiveness analysis of tacrolimus in liver transplant patients from real-world data[J].Pharmacoeconomics and Policy,2026,2(2):P.110-118,9.基金项目
supported by Shanghai Municipal Health Commission,China(Grant No.:20234Y0233) (Grant No.:20234Y0233)
the National Natural Science Foundation of China(Grant No.:82204502) (Grant No.:82204502)
Shanghai Pujiang Programme,China(Program No.:23PJD016) (Program No.:23PJD016)
Fudan University Talent Start-up Fund,China. ()